| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.22 | 0.1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |